Showing results (91-100 of 160) with videos related to
Sort By:
Pageof 16
Journal of Managed Care & Specialty Pharmacy|July 25, 2022
Oral treatments for outpatient COVID-19: Effectiveness and valueMolly Beinfeld, Kai Yeung, Melanie D Whittington, et al.Journal of Managed Care & Specialty Pharmacy|May 31, 2021
The effectiveness and value of nadofaragene firadenovec, oportuzumab monatox, and pembrolizumab for BCG-unresponsive non-muscle-invasive bladder cancerMolly Beinfeld, Steven J Atlas, Daniel Touchette, et al.Health Affairs (Project Hope)|November 11, 2008
Assessing the comparative effectiveness of a diagnostic technology: CT colonographySteven D Pearson, Amy B Knudsen, Roberta W Scherer, et al.Journal of Managed Care & Specialty Pharmacy|February 28, 2020
The Effectiveness and Value of Siponimod for Secondary Progressive Multiple SclerosisPatricia G Synnott, Lisa M Bloudek, Ravi Sharaf, et al.Journal of Managed Care & Specialty Pharmacy|August 31, 2021
Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myelomaMolly Beinfeld, Sei Lee, Brett McQueen, et al.Journal of Managed Care & Specialty Pharmacy|August 1, 2024
The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia BJyotirmoy Sarker, Jeffrey A Tice, David M Rind, et al.Journal of Managed Care & Specialty Pharmacy|January 31, 2019
The Effectiveness and Value of Lanadelumab and C1 Esterase Inhibitors for Prophylaxis of Hereditary Angioedema AttacksFoluso Agboola, Solomon Lubinga, Josh Carlson, et al.Journal of Managed Care & Specialty Pharmacy|March 1, 2021
The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitisRajshree Pandey, Daniel A Ollendorf, Katherine Fazioli, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 16, 2023
Designing a Value-Based Formulary for a Commercial Health Plan: A Simulated Case Study of Diabetes MedicationsYilin Chen, Aimee R Loucks, Sean D Sullivan, et al.Journal of Managed Care & Specialty Pharmacy|May 29, 2020
The Effectiveness and Value of Rivaroxaban and Icosapent Ethyl as Additive Therapies for Cardiovascular DiseasePatricia G Synnott, R Brett McQueen, Daniel A Ollendorf, et al.Pageof 16